| PE19.05 | Cervicovaginal microbiota affects the human ectocervical epithelial barrier as determined by in situ image analysis and protein profiling | E-poster | Microbiome & STI: impact on prevention |
| PE21.02 | CD40-targeted vaccine increases magnitude of HIV-Env specific responses | E-poster | Novel vaccine and other prevention approaches |
| PE29.01 | CCR5 antibody blockade protects rhesus macaques from rectal SHIV acquisition | E-poster | Treatment as prevention |
| PE04.04LB | Can the offer of regular HIV self-testing kits reduce time to HIV diagnosis in MSM? Results from the SELPHI RCT | E-poster | Clinical trial results |
| PE04.05LB | Can a theory-based SMS intervention improve the health service utilization of female entertainment workers in Cambodia? Findings from the Mobile Link Randomized Controlled Trial | E-poster | Clinical trial results |
| PE28.05 | Calcitriol decreases HIV-1 transfer from monocyte-derived dendritic cells to CD4+ T lymphocytes | E-poster | Transmission of HIV |
| PE16.24 | Building targets from the ground up: how local performance data can help reach HIV prevention goals | E-poster | Implementation science, including structural interventions, PrEP & VMMC |
| PU16.14 | Building public-private partnerships for pharmacy-based PrEP delivery in Kenya: willingness to collaborate among PrEP and pharmacy providers | Publication Only | Implementation science, including structural interventions, PrEP & VMMC |
| PE14.01 | Broadly neutralizing plasma antibodies effective against diverse autologous circulating viruses in infants with multivariant HIV-1 infection | E-poster | HIV sequencing insights including viral diversity and antiretroviral resistance |
| PE09.02 | Bridging the insight to action gap: using HCD methods to design organizational tools for stakeholders in South Africa in order to improve effectiveness of AGYW prevention programs | E-poster | Demand creation, market research, human-centred design |